On September 10, 2014, The U.S. Food and Drug Administration (US FDA) approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) for anti-obesity treatments in combination with a reduced-calorie diet and exercise. Contrave is distributed by Takeda Pharmaceuticals America Inc. of Deerfield, Illinois for Orexigen Therapeutics, Inc. of La Jolla, California. The FDA approved the[…]
FDA Approves Contrave – A Naltrexone Hydrochloride and Bupropion Hydrochloride Drug Combo
Anti-Obesity Product, Drug Research & Development API, FDA Approved 2014, OTC and Compounding Product Tags: BMIhigh blood pressure Sep 12, 2014
FDA Approves Ketorolac and Phenylephrine for Eye Surgery
Anti-Inflammatory, Antibacterial, Drug Research & Development API, FDA Approved 2014, OTC and Compounding Product Tags: high blood pressureintraocular pressure Jun 09, 2014
Approximately four million Americans undergo cataract surgery every year, so the recent FDA approval of Ketorolac and Phenylephrine on June 2, 2014 is timely and beneficial for many patients in the United States. Known as the brand name Omidria, the combination of Ketorolac and Phenylephrine to create an efficacious pupil-dilating agent has been deemed successful[…]
Amlodipine Besylate Is a Formidable ACE Inhibitor
Bulk Active Ingredient, Drug Research & Development API, Patent Expiration 2017 Tags: high blood pressure Jan 29, 2013
Known as the brand name Lotrel, Amlodipine Besylate plays an integral part of this powerful calcium channel blocker. Lotrel, which is marketed by Novartis, is a combination of amlodipine besylate and benazepril. The patent for this formidable medication expires on December 19, 2017, paving the way for a generic version of this blockbuster drug. With[…]
Valsartan Found Safe for Use in Adults and Children with Hypertension
Bulk Active Ingredient, Drug Research & Development API Tags: congestive heart failurehigh blood pressurehypertension Apr 17, 2012
Valsartan is used as a treatment for high blood pressure, as well as congestive heart failure. As part of a class of medications called angiotensin II receptor antagonists, valsartan impedes the action of natural substances in the body that cause a tightening of blood vessels, thus allowing a smoother blood flow to the heart. Also[…]